Reports are emerging about healthcare and pharmaceutical advertising spending in the US for 2023-2024. The topic appears to be part of a broader discussion about healthcare costs, prescription drug prices, and the pharmaceutical industry. Data and trends on digital ad spend, global life sciences, and overall ad spending are also being considered in the context of the US healthcare and pharma sectors.